Anavex 
Welcome,         Profile    Billing    Logout  
 2 Products   1 Disease  2 Products   1 Trial   214 News 
5 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
blarcamesine (Anavex 2-73) / Anavex
2021-004325-80: ANAVEX2-73 Extension Study for treatment in AD Extensie studie met ANAVEX2-73 voor de behandeling van AD

Not yet recruiting
2/3
325
Europe
ANAVEX2-73, ANAVEX2-73, Capsule, Oral solution
Anavex Germany GmbH, Anavex Germany GmbH
Alzheimer's Disease Ziekte van Alzheimer, Dementia Dementie, Diseases [C] - Nervous System Diseases [C10]
 
 
2019-003302-27: ANAVEX2-73 used for a new treatment in AD

Not yet recruiting
2/3
509
Europe
ANAVEX2-73, ANAVEX2-73, Capsule
Anavex Germany GmbH, ANAVEX Life Sciences Corp., Anavex Germany GmbH, ANAVEX Life Sciences Corp.
Alzheimer's Disease, Alzheimer's Disease, Diseases [C] - Nervous System Diseases [C10]
 
 
EXCELLENCE, NCT04304482: ANAVEX2-73 Study in Pediatric Patients With Rett Syndrome

Completed
2/3
92
Europe, Canada, RoW
ANAVEX2-73 oral liquid, Blarcamesine, Placebo oral liquid
Anavex Life Sciences Corp., Anavex Australia Pty Ltd., Anavex Germany GmbH
Rett Syndrome
06/23
06/23
ATTENTION-AD, NCT04314934: OLE of Phase 2b/3 Study ANAVEX2-73-AD-004

Completed
2/3
300
Europe, Canada, RoW
ANAVEX2-73, Blarcamesine
Anavex Life Sciences Corp., Anavex Australia Pty Ltd., Anavex Germany GmbH
Alzheimer Disease
06/24
06/24
ANAVEX 3-71 / Anavex
SZ-001, NCT06245213: A Study of ANAVEX3-71 in Adults With Schizophrenia

Active, not recruiting
2
71
US
ANAVEX3-71 oral capsules, Placebo oral capsules
Anavex Life Sciences Corp., COGNISION, Cognitive Research Corporation, Hassman Research Institute
Schizophrenia
06/25
06/25
Anavex Plus (blarcamsine/donepezil) / Anavex
No trials found
Anavex 1-41 / Anavex
No trials found
ANAVEX1066 / Anavex
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
blarcamesine (Anavex 2-73) / Anavex
2021-004325-80: ANAVEX2-73 Extension Study for treatment in AD Extensie studie met ANAVEX2-73 voor de behandeling van AD

Not yet recruiting
2/3
325
Europe
ANAVEX2-73, ANAVEX2-73, Capsule, Oral solution
Anavex Germany GmbH, Anavex Germany GmbH
Alzheimer's Disease Ziekte van Alzheimer, Dementia Dementie, Diseases [C] - Nervous System Diseases [C10]
 
 
2019-003302-27: ANAVEX2-73 used for a new treatment in AD

Not yet recruiting
2/3
509
Europe
ANAVEX2-73, ANAVEX2-73, Capsule
Anavex Germany GmbH, ANAVEX Life Sciences Corp., Anavex Germany GmbH, ANAVEX Life Sciences Corp.
Alzheimer's Disease, Alzheimer's Disease, Diseases [C] - Nervous System Diseases [C10]
 
 
EXCELLENCE, NCT04304482: ANAVEX2-73 Study in Pediatric Patients With Rett Syndrome

Completed
2/3
92
Europe, Canada, RoW
ANAVEX2-73 oral liquid, Blarcamesine, Placebo oral liquid
Anavex Life Sciences Corp., Anavex Australia Pty Ltd., Anavex Germany GmbH
Rett Syndrome
06/23
06/23
ATTENTION-AD, NCT04314934: OLE of Phase 2b/3 Study ANAVEX2-73-AD-004

Completed
2/3
300
Europe, Canada, RoW
ANAVEX2-73, Blarcamesine
Anavex Life Sciences Corp., Anavex Australia Pty Ltd., Anavex Germany GmbH
Alzheimer Disease
06/24
06/24
ANAVEX 3-71 / Anavex
SZ-001, NCT06245213: A Study of ANAVEX3-71 in Adults With Schizophrenia

Active, not recruiting
2
71
US
ANAVEX3-71 oral capsules, Placebo oral capsules
Anavex Life Sciences Corp., COGNISION, Cognitive Research Corporation, Hassman Research Institute
Schizophrenia
06/25
06/25
Anavex Plus (blarcamsine/donepezil) / Anavex
No trials found
Anavex 1-41 / Anavex
No trials found
ANAVEX1066 / Anavex
No trials found

Download Options